Recurrent supratentorial malignant gliomas in children: Long-term salvage therapy with oral etoposide

Archives of Neurology

Volumn 54, Issue 5, 1997, Pages 554-558

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETOPOSIDE; LOMUSTINE; NITROSOUREA; PROCARBAZINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG RESPONSE; FEMALE; FEVER; GLIOBLASTOMA; HUMAN; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALVAGE THERAPY; SIDE EFFECT; WEIGHT REDUCTION;

EID: 0030958836     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550170036012     Document Type: Article

References (36)

1. Duffner PK, Cohen ME, Myers MH, Heise HW. Survival of children with brain tumors: SEER program, 1973-1980. Neurology. 1986;36:597-601.
2. Cohen ME, Duffner PK. Supratentorial hemispheric astrocytomas. In: Brain Tumors in Children: Principles of Diagnosis and Treatment. New York, NY: Raven Press; 1984;10:173-192.
3. Dropcho EJ, Wisoff JH, Walker RW, Allen JC. Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol. 1987;22:355-364.
4. Marchese MJ, Chang CH. Malignant astrocytic gliomas in children. Cancer. 1990;65:2771-2778.
5. Dohrmann GJ, Farwell JR, Flannery JT. Glioblastoma multiforme in children. J Neurosurg. 1985;62:811-815.
6. Spostro R, Ertel U, Jenkin RDT, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial: a report from the Childrens Cancer Study Group. J Neurooncol. 1989;7:165-177.
7. Phuphanich S, Edwards MSB, Levin VA, et al. Supratentorial malignant gliomas of childhood: results of treatment with radiation therapy and chemotherapy. J Neurosurg. 1984;60:495-499.
8. Pendergrass TW, Milstein JM, Geyer JR, et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol. 1987;5:1221-1231.
9. Allen JC, Nelson L High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg. 1981;55:749-756.
10. van Eys J, Cangir A, Goody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol, 1985;3:237-243.
11. Bertolone SJ, Baum ES, Krivit W, Hammond GD. A phase II study of cisplatin therapy in recurrent childhood brain tumors. J Neurooncol. 1989;7:5-11.
12. Chamberlain MC. Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol. 1993;15:133-139.
13. Duffner P, Horowitz M, Krischer J, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725-1731.
14. Finlay JL, Geyer JR, Turski PA, et al. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. J Neurooncol. 1994;21:255-265.
15. Lewis IJ, Stevens MCG, Pearson A, Pinkerton R, Stevens R. Phase II study of carboplatin in children's tumours. Am Soc Clin Oncol. 1993;12:121. Abstract.
16. Finlay JL, August C, Packer R, et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neurooncol. 1990;9:239-248.
17. Walker RW, Allen JC. Treatment of recurrent primary intracranial childhood tumors with cis-diamminedichloroplatinum. Ann Neurol. 1983;14:371-372. Abstract.
18. Finlay J, Boyett J, Yates A, et al. A randomized phase III trial of chemotherapy for childhood high-grade astrocytoma: report of the Childrens Cancer Group trial, CCG-945. Proc Am Soc Clin Oncol. 1991;10:308. Abstract.
19. Chamberlain MC. Recurrent supratentorial gliomas: salvage therapy with oral etoposide. Ann Neurol. 1996;40:335. Abstract.
20. Chamberlain MC. Recurrent cerebellar gliomas: salvage therapy with oral VP-16. Ann Neurol. 1994;36:507.
21. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol. 1996;13:2072-2076.
22. Lansky LL, List MA, Lansky SB, et at. Toward the development of a play performance scale of children (PPSC). Cancer. 1985;56:1837-1840.
23. Levin VA, Silver P. Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys. 1990;18:321-324.
24. Phillips PC, Carson BS, Calvin OM. Do topoisomerase inhibitors have a role in brain tumor chemotherapy? detection of topoisomerase I and II in pediatric brain tumors. Ann Neurol. 1990;28:218. Abstract.
25. Hainsworth JD, Greco FA. Etoposide: twenty years later. Ann Oncol. 1995;6: 325-341.
26. Carney DN. The pharmacology of intravenous and oral etoposide. Cancer. 1991;67:299-302.
27. Fleming RA, Miller AA, Stewart CF. Etoposide: an update. Clin Pharm. 1989;8:274-293.
28. Clark PI, Slevin ML. The clinical pharmacology of etoposide and teniposide. Clin Pharm. 1987;12:223-252.
29. O'Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE. Etoposide (VP-16-213): current status of an active anticancer drug. N Engl J Med. 1985;312:692-700.
30. Greco FA. Future directions for etoposide therapy. Cancer. 1991;67:315-318.
31. Slevin ML. The clinical pharmacology of etoposide. Cancer. 1991;67:319-329.
32. Smyth RD, Pfeffer M, Scalzo A, Comis RL. Bioavailability and pharmacokinetics of etoposide (VP-16). Semin Oncol. 1985;1(suppl 2):48-51.
33. Greco FA, Johnson DH, Hainsworth JD. Chronic oral etoposide. Cancer. 1991;67:303-309.
34. Tirelli U, D'Incalci M, Canetta R, et al. Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol. 1984;2:432-436.
35. Fulton D, Urtasun R, Forsyth P. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neurooncol. 1996;27:149-155.
36. Minami H, Ando Y, Sakai S, Shimokata K. Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide. J Clin Oncol. 1995;13:191-199.